Hap Trading, LLC Biomea Fusion, Inc. Transaction History
Hap Trading, LLC
- $1.06 Trillion
- Q2 2025
A detailed history of Hap Trading, LLC transactions in Biomea Fusion, Inc. stock. As of the latest transaction made, Hap Trading, LLC holds 24,800 shares of BMEA stock, worth $54,808. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24,800Holding current value
$54,808% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding BMEA
# of Institutions
99Shares Held
23.2MCall Options Held
1.08MPut Options Held
359K-
Heights Capital Management, Inc San Francisco, CA3.84MShares$8.48 Million1.84% of portfolio
-
Cormorant Asset Management, LP Boston, MA3.57MShares$7.89 Million0.65% of portfolio
-
Black Rock Inc. New York, NY2.34MShares$5.18 Million0.0% of portfolio
-
Aisling Capital Management LP New York, NY2.05MShares$4.53 Million1.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.88MShares$4.15 Million0.0% of portfolio
About Biomea Fusion, Inc.
- Ticker BMEA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,290,600
- Market Cap $64.7M
- Description
- Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...